Recent Finacing
Recent Raise
Provesica is a clinical-stage biotech based in Cambridge developing XEN-D0501, a therapeutic candidate for overactive bladder that completed Phase 1 and is progressing toward Phase 2 trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors